HC Wainwright Has Pessimistic Outlook of TSE:GLX Q1 Earnings
Bradmer Pharmaceuticals Inc. (TSE:GLX – Free Report) – Analysts at HC Wainwright cut their Q1 2025 EPS estimates for Bradmer Pharmaceuticals in a research report issued on Monday, March 31st. HC Wainwright analyst M. Colonnese now anticipates that the company will post earnings of ($0.76) per share for the quarter, down from their prior estimate […]
